Fort Lee, New Jersey, United States Palisade Capital Management appeared to be the VC, which was created in 1995. The company was established in North America in United States. The main department of described VC is located in the Fort Lee.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Palisade Capital Management, startups are often financed by Triathlon Medical Venture Partners, Oxford Bioscience Partners, Giza Venture Capital. The meaningful sponsors for the fund in investment in the same round are General Electric Pension Trust, Wexford Capital, WR Hambrecht. In the next rounds fund is usually obtained by Triathlon Medical Venture Partners, Saints Capital, Oxford Bioscience Partners.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Mitralign, ElMindA, Ikonisys. Among the most successful fund investment fields, there are Medical Device, Software.
The overall number of key employees were 13.
The top amount of exits for fund were in 2017. The high activity for fund was in 2004. Speaking about the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this Palisade Capital Management works on 1 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anthill Studio | Andhra Pradesh, Hyderabad, India |
| BESTSELLER Foundation | - |
| Bozhong.com | China, Guangdong, Guangzhou |
| Eliad Holdings | - |
| FinLab | Frankfurt, Germany, Hessen |
| Fitbit | California, San Francisco, United States |
| GITS Foods | India, Maharashtra, Mumbai |
| HuaKong Equity Investment | - |
| Jingpu Pengyuan Fund | - |
| Junrun Capital | China, Ningbo, Zhejiang |
| Juren Capital | China, Hangzhou, Zhejiang |
| Ministerio de Economia y Competitividad | Community of Madrid, Madrid, Spain |
| Partners Innovation Fund | Boston, Massachusetts, United States |
| Presidio Ventures | California, Santa Clara, United States |
| Qiandao Fund | Beijing, Beijing, China |
| Samlyn Capital | New York, New York, United States |
| Sapien Ventures | Australia, New South Wales, Sydney |
| Sharewin Investment | China, Shanghai |
| Summerfield Capital Management | New York, New York, United States |
| Translunar One | Austin, Texas, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ElMindA | $28M | 16 Nov 2015 | Israel, Tel Aviv District, Israel | ||
Brickell Biotech | $7M | 26 Feb 2013 | Miami, Florida, United States | ||
Mitralign | $24M | 31 Dec 2007 | Massachusetts, United States | ||
Language Weaver | $4M | 07 Oct 2004 | Los Angeles, California, United States | ||
Achieve3000 | $4M | 22 Jul 2004 | Lakewood, New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ElMindA | $28M | 16 Nov 2015 | Israel, Tel Aviv District, Israel | ||
Brickell Biotech | $7M | 26 Feb 2013 | Miami, Florida, United States | ||
Mitralign | $24M | 31 Dec 2007 | Massachusetts, United States | ||
Language Weaver | $4M | 07 Oct 2004 | Los Angeles, California, United States | ||
Achieve3000 | $4M | 22 Jul 2004 | Lakewood, New Jersey, United States |
